Recent Research Funding

We receive funding from a variety of sources that recognize the value of our high-impact research.

  • Corneal Endothelium – Extracellular Matrix Interactions. Yongho Bae (Co-Investigator). NIH/NEI. $1,792,987. 4/1/2024-4/1/2029.
  • Computational Image Analysis of Renal Transplant Biopsies to Predict Graft Outcome”. John Tomaszewski (Co-Investigator). NIH. $285,930. 9/1/2023-7/1/2028.
  • Biomimetic Vascular Matrix for Vascular Smooth Muscle Cell Mechanobiology and Pathology. Vincent Tutino (Co-Investigator). National Institutes of Health – NHLBI. $4,000,000. 9/1/2023-8/1/2027.
  • Biomimetic Vascular Matrix for Vascular Smooth Muscle Cell Mechanobiology and Pathology. Yongho Bae (Principal Investigator). NIH/NHLBI. $2,266,072. 9/1/2023-6/1/2027.
  • Immunomodulatory Therapy After Resuscitation From Cardiac Arrest. Olga Pletnikova (Consultant). NIH. 1/1/2022-12/1/2026.
  • Liquid and endovascular coil biopsy for understanding sex differences in Intracranial Aneurysms. Vincent Tutino (Co-Investigator). CNS – Joint CV Section/CNSF Young Investigator’s Award. $150,000. 10/1/2023-9/1/2026.
  • Development of a Molecular Diagnostic to Identify Dangerous Intracranial Aneurysms. Vincent Tutino (Co-Principal Investigator). National Institutes of Health – NINDS. $2,900,000. 9/1/2023-8/1/2026.
  • SBIR: Development of a Molecular Diagnostic to Identify Dangerous Intracranial Aneurysms. John Kolega (Principal Investigator). National Institutes of Health (Federal Flow Through via Neurovascular Diagnostics Incorporated ). $393,885. 9/1/2023-8/1/2026.
  • The Effect of WTC Exposure on Thyroid Cancer in the Survivor Population. Scott Doyle (Co-Investigator). NIH. $100,297. 7/1/2023-6/1/2026.
  • Quantitative Risk Model for Predicting Likelihood of Recurrence for Oral Cavity Cancer. Scott Doyle (Principal Investigator). NIH. $2,003,024. 4/1/2020-3/1/2026.
  • Discovery and Development of novel inhibitors and other potential targets to reduce or prevent arterial stiffening. Yongho Bae (Principal Investigator). Center of Excellence in Bioinformatics and Life Sciences, University at Buffalo. $80,000. 12/1/2023-11/1/2025.
  • Generalizable Deep-Learning Algorithms for IA Management from Computed Tomography Angiography Imaging?. Vincent Tutino (Other). Brain Aneurysm Foundation. $50,000. 10/1/2024-9/1/2025.
  • Exploring the Relationship between Imaging- and Blood-Based Aneurysm Biomarkers and the Pathobiology of the Aneurysm Wall. Vincent Tutino (Other). Brain Aneurysm Foundation. $35,000. 10/1/2023-9/1/2025.
  • CAT: Development of a molecular diagnostic to identify dangerous intracranial aneurysms. Vincent Tutino (Principal Investigator). Neurovascular Diagnostics, Inc. $176,000. 7/1/2024-7/1/2025.
  • Evaluation of a tissue compressive device for the enhanced retrieval of lymph nodes from fatty specimens. John Tomaszewski (Principal Investigator). UB Center for Advanced Technology in Big Data & Health Sciences (UB CAT). $27,391. 10/1/2023-6/1/2025.
  • Drug Discovery Incubator Program Award (Hit to lead phase). Yongho Bae (Principal Investigator). Empire Discovery Institute. $750,000. 6/1/2024-5/1/2025.
  • An AI-Enhanced Angiographic System to Guide Endovascular Treatment of Intracranial Aneurysms. Vincent Tutino (Co-Investigator). National Science Foundation. $1,000,000. 5/1/2023-4/1/2025.
  • Initiative for Private and Secure Collaborative AI Training in Computational Pathology. Scott Doyle (Principal Investigator). Clinical and Translational Science Institute (CTSI). $50,000. 1/1/2024-3/1/2025.
  • Collaborative Research: Control of Information Processing and Learning in Neuronal Networks through Light-mediated Programming of Genomic Networks. Yongho Bae (Co-Principal Investigator). National Science Foundation. $366,284. 2/1/2021-1/1/2025.
  • Buffalo Bioimaging Brain Bank for Neurological Disorders (B4ND). Olga Pletnikova (Co-Principal Investigator). Translational Pilot Studies Program University at Buffalo Clinical and Translational Science Institute Clinical and Translational Science Award (CTSA). $68,000. 1/1/2024-12/1/2024.